The journal didn't disclose its funding source anywhere within the publication. Bioethics.net blasts this fraudulent journal on the grounds that its Merck-friendly findings could be given to primary-care physicians, and falsely persuade them in favor of using the drug.
Apparently, it's already happened-- and in a big way. Remember Vioxx? The one that was recalled due to ion channel complications? The Australasian Journal of Bone and Joint Medicine was implicated in an Australian civil suit regarding a heart attack caused by Vioxx.
- Elsevier To Create New Guidelines For Pharmaceutical Article Reprint, Compilation And Custom Publications
- Elsevier's New Custom Publication Guidelines Set New Standards For Publishing Pharma-Sponsored Content
- Merck Wins Appeal Of First VIOXX(R) Case To Go To Trial
- Elsevier published *six* fake journals.
- Elsevier's Leadership In EProducts Demonstrated At The 2009 PROSE Awards